The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
about
Healthcare expenditure of multiple sclerosis patients in 2013: A nationwide study based on French health administrative databasesPositive predictive values of peripheral arterial and venous thrombosis codes in French hospital database.Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.A visual approach of care pathways from the French nationwide SNDS database - from population to individual records: the ePEPS toolbox.Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting.The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.The 2015 and 2016 terrorist attacks in France: was there a short-term impact on hospitalizations for cardiovascular disease?Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohortDevelopment of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in FranceEpidemiological and economic burden of potentially HPV-related cancers in FranceExtra cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis
P2860
Q41716475-EF3345C5-E709-456A-A79C-09D3CFBD676EQ47237796-B380CA8A-7194-4AC9-904D-F4D8860230A8Q47803775-F1F11012-39BB-428F-AEAB-A624641DF08AQ47968918-4D29B8C3-C351-42BA-AB2E-8361906383B3Q50217749-94DA1792-1C85-491B-B95F-C05A26E8DED5Q52604646-0811A5DE-4917-40CF-8BAB-5E318220DAEFQ52618065-3383B73E-BFA4-4254-A227-93FBC4E1BBAEQ55084973-F6633565-05F8-4912-B590-EE4F0C9EA424Q57142285-FD908643-13AB-4734-B92E-8471325B110DQ57259547-C7D2F74B-03F8-45F1-866E-D121C3E809AAQ58713772-FD19FE7A-C4E4-4B4E-8FEB-99770FFCA717Q58757748-0F0E0253-7BF8-4573-ADB9-F4DD9C89C74C
P2860
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The national healthcare system ...... ools for pharmacoepidemiology.
@en
type
label
The national healthcare system ...... ools for pharmacoepidemiology.
@en
prefLabel
The national healthcare system ...... ools for pharmacoepidemiology.
@en
P2093
P2860
P50
P356
P1476
The national healthcare system ...... ools for pharmacoepidemiology.
@en
P2093
Cécile Droz
Patrick Blin
Régis Lassalle
P2860
P304
P356
10.1002/PDS.4233
P577
2017-05-24T00:00:00Z